ALEXANDRIA, Va., Aug. 26 -- United States Patent no. 12,398,201, issued on Aug. 26, was assigned to New York University (New York).
"Tau single domain antibodies" was invented by Einar M. Sigurdsson (Scarsdale, N.Y.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure is directed to single domain antibodies that bind to tau and the use of these antibodies for the treatment and diagnosis of tauopathies. The present disclosure is also directed to polynucleotides encoding the tau single domain antibodies, therapeutic vectors comprising these polynucleotides and methods of administering these therapeutic vectors for the treatment of tauopathies."
The patent was filed on Feb. 19, 2019, under App...